Rigel Pharmaceuticals, Inc.
RIGL
$41.50
-$0.49-1.17%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 40.57% | -0.29% | 26.52% | 24.46% | -0.90% |
Total Receivables | -3.95% | -0.16% | 36.11% | 5.78% | 5.06% |
Inventory | -3.43% | 67.20% | 19.77% | -20.23% | 40.94% |
Prepaid Expenses | 13.37% | -19.06% | -3.47% | 2.11% | -20.71% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -14.70% | -- | -- | -- | -- |
Total Current Assets | 19.67% | 8.48% | 26.90% | 12.40% | 2.42% |
|
|||||
Total Current Assets | 19.67% | 8.48% | 26.90% | 12.40% | 2.42% |
Net Property, Plant & Equipment | -10.57% | 308.58% | -32.94% | -25.33% | -20.77% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -2.22% | -2.17% | -2.12% | -2.08% | -2.04% |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 175.99% | 5.64% | -69.86% | 0.55% | 9.66% |
Total Assets | 17.48% | 7.32% | 17.61% | 8.58% | 1.49% |
|
|||||
Total Accounts Payable | 84.37% | 18.42% | -12.48% | -37.77% | -33.92% |
Total Accrued Expenses | 8.74% | -10.31% | 6.07% | 40.19% | 16.51% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 49.81% | 102.08% | 1,521.67% | -27.07% | -96.13% |
Total Finance Division Other Current Liabilities | 92.79% | -3.70% | -4.36% | -69.34% | 0.17% |
Total Other Current Liabilities | 92.79% | -3.70% | -4.36% | -69.34% | 0.17% |
Total Current Liabilities | 30.03% | 5.26% | 16.55% | -7.39% | -19.88% |
|
|||||
Total Current Liabilities | 30.03% | 5.26% | 16.55% | -7.39% | -19.88% |
Long-Term Debt | -55.89% | -8.09% | -7.37% | 0.07% | 17.41% |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -17.36% | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | 0.00% | -- | -- | -- |
Total Liabilities | -20.71% | -2.04% | 4.31% | -2.70% | 0.08% |
|
|||||
Common Stock & APIC | 0.27% | 0.28% | 0.26% | 0.20% | 0.20% |
Retained Earnings | 4.32% | 0.82% | 1.02% | 0.88% | -0.07% |
Treasury Stock & Other | 400.00% | -120.00% | -9.09% | 222.22% | -80.00% |
Total Common Equity | 341.29% | 464.69% | 122.47% | 51.07% | 5.55% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 341.29% | 464.69% | 122.47% | 51.07% | 5.55% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 341.29% | 464.69% | 122.47% | 51.07% | 5.55% |
|